PP
ALXN
PDT Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,104
| Closed | -$1.89M | – | 941 |
|
|
2020
Q4 | $1.89M | Sell |
12,104
-43,647
| -78% | -$6.82M | 0.13% | 252 |
|
|
2020
Q3 | $6.38M | Sell |
55,751
-11,889
| -18% | -$1.36M | 0.42% | 87 |
|
|
2020
Q2 | $7.59M | Sell |
67,640
-41,519
| -38% | -$4.66M | 0.52% | 62 |
|
|
2020
Q1 | $9.8M | Buy |
109,159
+25,028
| +30% | +$2.25M | 0.78% | 11 |
|
|
2019
Q4 | $9.1M | Buy |
+84,131
| New | +$9.1M | 0.56% | 62 |
|
|
2019
Q3 | – | Sell |
-79,500
| Closed | -$10.4M | – | 499 |
|
|
2019
Q2 | $10.4M | Hold |
79,500
| – | – | 0.62% | 36 |
|
|
2019
Q1 | $10.7M | Sell |
79,500
-37
| -0% | -$5K | 0.61% | 37 |
|
|
2018
Q4 | $7.74M | Buy |
79,537
+25
| +0% | +$2.43K | 0.43% | 87 |
|
|
2018
Q3 | $11.1M | Buy |
+79,512
| New | +$11.1M | 0.46% | 60 |
|
|
2015
Q4 | – | Sell |
-60,440
| Closed | -$9.45M | – | 1075 |
|
|
2015
Q3 | $9.45M | Buy |
+60,440
| New | +$9.45M | 0.21% | 127 |
|
|
2015
Q2 | – | Sell |
-60,173
| Closed | -$10.4M | – | 1741 |
|
|
2015
Q1 | $10.4M | Buy |
60,173
+55,473
| +1,180% | +$9.61M | 0.26% | 86 |
|
|
2014
Q4 | $870K | Sell |
4,700
-1,000
| -18% | -$185K | 0.08% | 358 |
|
|
2014
Q3 | $945K | Sell |
5,700
-72,131
| -93% | -$12M | 0.02% | 674 |
|
|
2014
Q2 | $12.2M | Sell |
77,831
-82,559
| -51% | -$12.9M | 0.32% | 57 |
|
|
2014
Q1 | $24.4M | Buy |
160,390
+158,271
| +7,469% | +$24.1M | 0.59% | 22 |
|
|
2013
Q4 | $282K | Sell |
2,119
-20,316
| -91% | -$2.7M | 0.03% | 537 |
|
|
2013
Q3 | $2.61M | Sell |
22,435
-90,724
| -80% | -$10.5M | 0.07% | 385 |
|
|
2013
Q2 | $10.4M | Buy |
+113,159
| New | +$10.4M | 0.26% | 78 |
|